Pulmonary cryptococcosis mimicking metastatic progression despite systemic disease stability in advanced colon cancer: A case report and literature review.

Medicine (Baltimore)Oct 2, 2026

Yu-Cai Jiang, Bi-Jin Zheng, Ming-Gui Fu et al.

✦ AI-curated · Sources linked

Case in brief

A patient with advanced colon cancer undergoing chemotherapy presented with new pulmonary nodules on imaging, despite stable systemic disease and declining tumor markers. Initially suspected to be metastatic progression, further evaluation revealed positive tests for pulmonary cryptococcosis. Treatment with fluconazole was initiated, leading to marked regression of the lung nodules on follow-up imaging.

Diagnostic / clinical pearl

Clinicians should consider opportunistic infections like cryptococcosis when new pulmonary nodules appear in patients with stable cancer, as this can prevent misinterpretation of imaging findings as metastatic progression.

Why it matters

This case highlights the importance of integrating clinical stability, imaging results, and targeted testing to avoid unnecessary treatment escalation in cancer patients.

Source

Published in Medicine (Baltimore). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.